THE BASIC PRINCIPLES OF TRASTUZUMAB BIOSIMILAR

Trastuzumab blocks the activity of HER2 and triggers a type of immune reaction that kills cells which have loads of HER2. It is just a sort of targeted therapy drug called a monoclonal antibody.Look at together with your health care Specialist if any of the subsequent side effects proceed or are bothersome or if you have any questions about them:It